William Gibson

William Gibson currently serves as Senior Director of Alzheimer’s Disease Marketing within the Neurology Business Unit at Eisai US, where responsibilities include leading thought leader engagement, executing primary care messaging, and driving launch readiness efforts for Alzheimer’s disease assets in collaboration with Biogen. Previously, William held various senior roles at Bristol-Myers Squibb, including Director of Immuno-Oncology Dosing Strategy and Director of Global Commercialization for Alzheimer's Disease, contributing significantly to product launches and market access strategies. William's early career included positions at IMS Health and Sudler & Hennessey, highlighting a robust background in marketing and commercialization within the pharmaceutical sector. William holds an MBA in Marketing from Rutgers University and a BA in Economics from Gettysburg College.